97789361 - RP2

Information

• Trademark
• 97789361

• Source

• Serial Number

  97789361

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  February 10, 2023
  2 years ago

• Transaction Date

  October 18, 2023
  a year ago

• Status Date

  October 18, 2023
  a year ago

• Location Date

  March 01, 2023
  2 years ago

• Status Code

  601

• Current Location

  NEW APPLICATION PROCESSING

• Attorney Docket Number

  221834-00048

  Attorney Name

  Melanie Howard

• Owners

  • Replimune Limited

Case File Statements

• GS0051: Pharmaceutical preparations; viruses; viruses for the treatment of disease; viruses for the treatment of cancer; viruses for inducing immune response; pharmaceuticals; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response; vaccines; immunotherapy products; gene therapy products; Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders
• PM0001: RP TWO
• GS0421: Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid

Case File Event Statements

• 10/18/2023 - a year ago

  6 - ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Type: MAB1

• 10/17/2023 - a year ago

  5 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR

• 10/18/2023 - a year ago

  4 - ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Type: MAB1

• 10/18/2023 - a year ago

  3 - ABANDONMENT - EXPRESS MAILED Type: ABN1

• 3/1/2023 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/14/2023 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP